Adaptive Biotechnologies(us:ADPT)
7.41
-6.68%
Updated on 2025-04-03
Open:7.36
Close:7.41
High:8.07
Low:7.36
Prev Close:7.94
Volume:2.83M
Turnover:21.33M
Turnover Ratio:1.90%
Shares:148.58M
MarketCap:1.10B
About Adaptive Biotechnologies
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Company Name: Adaptive Biotechnologies
Address: 1165 Eastlake Avenue East
Employees: 709
Fiscar Year: 12-31
IPO Date: 2019-06-27
Website: http://www.adaptivebiotech.com
CIK: 1478320
View all SEC Filings
About
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Address:1165 Eastlake Avenue East
Website:http://www.adaptivebiotech.com
Market Movers